More about

Endometrial Cancer

News
December 16, 2020
2 min read
Save

Combination extends OS in advanced endometrial cancer

Combination extends OS in advanced endometrial cancer

Pembrolizumab plus lenvatinib improved outcomes compared with chemotherapy for women with advanced endometrial cancer, according to topline data released by the agents’ manufacturers.

News
November 12, 2020
3 min read
Save

Physical activity before, after endometrial cancer diagnosis improves survival outcomes

Physical activity before, after endometrial cancer diagnosis improves survival outcomes

Recreational physical activity appeared associated with improved survival outcomes among women with endometrial cancer, according to study results published in Journal of Clinical Oncology.

News
October 06, 2020
5 min read
Save

Uterine microbiome may explain racial disparity in endometrial cancer mortality

Uterine microbiome may explain racial disparity in endometrial cancer mortality

Uterine microbial diversity appeared higher among Black women diagnosed with endometrial cancer compared with their white counterparts, according to study results.

News
August 10, 2020
2 min read
Save

Caffeinated coffee consumption ‘clearly’ does not increase cancer risk, studies show

Caffeinated coffee consumption ‘clearly’ does not increase cancer risk, studies show

Consumption of caffeinated coffee does not appear to increase risk for various cancer types, according to a review article published in The New England Journal of Medicine.

News
July 30, 2020
2 min read
Save

Chemotherapy, surgery for gynecologic cancer not linked to higher COVID-19 mortality risk

Chemotherapy, surgery for gynecologic cancer not linked to higher COVID-19 mortality risk

Women who underwent chemotherapy or surgery for gynecologic cancer and also had COVID-19 infection did not appear at significantly increased risk for death due to the novel coronavirus, according to study findings published in Cancer.

News
October 03, 2019
2 min read
Save

Avelumab active in mismatch repair-deficient endometrial cancer

Avelumab induced promising activity among women with mismatch repair-deficient endometrial cancer regardless of PD-L1 status, according to results of a prospective phase 2 trial published in Journal of Clinical Oncology.

News
September 17, 2019
2 min read
Save

FDA announces international collaboration, approves pembrolizumab plus lenvatinib for endometrial cancer

FDA announces international collaboration, approves pembrolizumab plus lenvatinib for endometrial cancer

The FDA, in conjunction with decisions by regulatory agencies in Australia and Canada, granted accelerated approval to pembrolizumab in combination with lenvatinib for the treatment of certain women with advanced endometrial carcinoma, according to a press release from the agency.

News
September 01, 2019
2 min read
Save

10 updates for Gynecologic Cancer Awareness Month

September is Gynecologic Cancer Awareness Month, an awareness campaign launched by the Foundation for Women’s Cancer.

News
August 05, 2019
3 min read
Save

Chemoradiotherapy improves survival in high-risk endometrial cancer

Chemoradiotherapy significantly improved OS and failure-free survival compared with pelvic radiotherapy alone among women with high-risk endometrial cancer, according to results from the PORTEC-3 randomized phase 3 trial published in The Lancet Oncology.

News
November 25, 2011
2 min read
Save

CPS-II: Adult weight gain associated with increased risk for endometrial cancer

AACR Frontiers in Cancer Prevention Research

View more